MDXH
MDxHealth SA
NASDAQ · Healthcare · Medical - Diagnostics & Research · BE
$0.63
−6.21%Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$0.19
- Revenue actual
- $27.2M
- Revenue estimate
- $26.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -26.0%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $2.50
- PT range
- $2.00 – $3.00
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.19 | -$0.18 | Beat 6.91% | $27.2M |
| May 13, 2026 | -$0.14 | -$0.19 | Miss -31.35% | $23.9M |
| Nov 12, 2025 | -$0.12 | -$0.16 | Miss -33.33% | $53.2M |
| May 14, 2025 | -$0.13 | -$0.19 | Miss -46.15% | $48.1M |
| Feb 26, 2025 | -$0.21 | -$0.14 | Beat 33.33% | $24.7M |
| Aug 21, 2024 | -$0.26 | -$0.31 | Miss -19.23% | $42.0M |
| May 1, 2024 | -$0.30 | -$0.31 | Miss -3.33% | $38.7M |
| Mar 6, 2024 | -$0.11 | -$0.39 | Miss -254.55% | $19.4M |
| Aug 23, 2023 | -$0.32 | -$0.30 | Beat 6.25% | $16.7M |
| May 15, 2023 | -$0.40 | -$0.05 | Beat 87.50% | $24.0M |
| Mar 8, 2023 | -$0.75 | -$1.10 | Miss -46.67% | — |
| Oct 27, 2022 | -$0.55 | -$0.05 | Beat 90.91% | $13.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026